| Perindopril |
20090313 |
Stopress, Tablet, 4, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A., Полша |
Pharmaceutical Works POLPHARMA S.A. Poland |
4.6 |
0.92 |
5.52 |
7% |
0.32 |
4.92 |
0.98 |
5.9 |
20% |
0.92 |
5.84 |
1.17 |
7.01 |
|
КЦРР-1513/18.10.2012 |
02.11.2012 |
02.11.2012 |
Активен |
1409 |
| Perindopril |
20090314 |
Stopress, Tablet, 8, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A., Полша |
Pharmaceutical Works POLPHARMA S.A. Poland |
8.7 |
1.74 |
10.44 |
7% |
0.61 |
9.31 |
1.86 |
11.17 |
20% |
1.74 |
11.05 |
2.21 |
13.26 |
|
КЦРР-1513/18.10.2012 |
02.11.2012 |
02.11.2012 |
Неактивен |
1410 |
| Perindopril |
20090313 |
Stopress, Tablet, 4, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A., Полша |
Pharmaceutical Works POLPHARMA S.A. Poland |
4.6 |
0.92 |
5.52 |
7% |
0.32 |
4.92 |
0.98 |
5.9 |
20% |
0.92 |
5.84 |
1.17 |
7.01 |
|
КЦРР-1513/18.10.2012 |
02.11.2012 |
02.11.2012 |
Неактивен |
1409 |
| Iodine Ioflupane (123I) |
EU/1/19/1372/002 |
Striascan, Solution for injection, 74 MBq/ml - 5 ml, -, Pack: 1 vial, glass |
CIS Bio International, Франция |
CIS Bio International, Франция |
1054 |
210.8 |
1264.8 |
4% |
10 |
1064 |
212.8 |
1276.8 |
16% |
25 |
1089 |
217.8 |
1306.8 |
|
НСР-20567/09.01.2020 Предварително изпълнение |
09.01.2020 |
02.02.2020 |
Активен |
16842 |
| Olodaterol |
20130417 |
Striverdi Respimat, Inhalation solution, 2,5, mcg, Pack: 1 respimat inhaler and 1 cartridge (60 doses) |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH &Co.KG, Германия |
41.07 |
8.21 |
49.28 |
4% |
1.64 |
42.71 |
8.54 |
51.25 |
16% |
6.57 |
49.28 |
9.86 |
59.14 |
корекц. НСР-7731/17.12.2015 |
НСР-7563/24.11.2015 (допуска предварително изпълнение); НСР-14917/25.01.2018 |
02.12.2015 |
02.03.2018 |
Заличен |
4113 |
| Olodaterol |
20130417 |
Striverdi Respimat, Inhalation solution, 2,5, mcg, Pack: 1 respimat inhaler and 1 cartridge (60 doses) |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH &Co.KG, Германия |
41.07 |
8.21 |
49.28 |
4% |
1.64 |
42.71 |
8.54 |
51.25 |
16% |
6.57 |
49.28 |
9.86 |
59.14 |
корекц. НСР-7731/17.12.2015 |
НСР-7563/24.11.2015 (допуска предварително изпълнение) |
02.12.2015 |
02.12.2015 |
Неактивен |
4113 |
| Fat emulsions |
ІІ-6806/30.01.2003 г. |
Structolipid 20% emulsion for intravenous infusion, Emulsion for infusion, Purified structured triglyceride 20 g/100 ml - 250 ml, ml, Pack: 10 |
Fresenius Kabi AB, Швеция |
Fresenius Kabi AB, SE – 751 74 Uppsala, Sweden |
340.55 |
68.11 |
408.66 |
4% |
10 |
350.55 |
70.11 |
420.66 |
16% |
25 |
375.55 |
75.11 |
450.66 |
|
НСР-1443/10.10.2013; НСР-16908/28.09.2018 |
19.11.2013 |
02.11.2018 |
Заличен |
2218 |
| Fat emulsions |
ІІ-6806/30.01.2003 г. |
Structolipid 20% emulsion for intravenous infusion, Emulsion for infusion, Purified structured triglyceride 20 g/100 ml - 250 ml, ml, Pack: 10 |
Fresenius Kabi AB, Швеция |
Fresenius Kabi AB, SE – 751 74 Uppsala, Sweden |
340.55 |
68.11 |
408.66 |
4% |
10 |
350.55 |
70.11 |
420.66 |
16% |
25 |
375.55 |
75.11 |
450.66 |
|
НСР-1443/10.10.2013 |
19.11.2013 |
19.11.2013 |
Неактивен |
2218 |
| Fat emulsions |
ІІ-6806/30.01.2003 г. |
Structolipid 20% emulsion for intravenous infusion, Emulsion for infusion, Purified structured triglyceride 20 g/100 ml - 250 ml, ml, Pack: 10 |
Fresenius Kabi AB, Швеция |
Fresenius Kabi AB, SE – 751 74 Uppsala, Sweden |
562.03 |
112.41 |
674.44 |
4% |
10 |
572.03 |
114.41 |
686.44 |
16% |
25 |
597.03 |
119.41 |
716.44 |
|
КЦ-1015/02.07.2009 |
16.07.2009 |
16.07.2009 |
Неактивен |
2218 |
| Morphine |
20030413 |
Substitol, prolonged-release capsule, hard, 120, mg, Pack: 30 |
Mundipharma GmbH, Австрия |
Bard Pharmaceutical Ltd., UK; Mundipharma GmbH, Germany; Mundipharma Ges.m.b.H, Austria |
71.23 |
14.25 |
85.48 |
4% |
2.85 |
74.08 |
14.82 |
88.9 |
16% |
11.4 |
85.48 |
17.1 |
102.58 |
Промяна на обстоятелства НСР-15297/23.03.2018 |
КЦ-692/09.03.2009 |
24.03.2009 |
02.05.2018 |
Активен |
636 |
| Morphine |
II-4222/16.02.2009 |
Substitol, prolonged-release capsule, hard, 120, mg, Pack: 30 |
Mundipharma GmbH, Австрия |
Bard Pharmaceutical Ltd., UK; Mundipharma GmbH, Germany; Mundipharma Ges.m.b.H, Austria |
71.23 |
14.25 |
85.48 |
4% |
2.85 |
74.08 |
14.82 |
88.9 |
16% |
11.4 |
85.48 |
17.1 |
102.58 |
|
КЦ-692/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
636 |
| Morphine |
20030414 |
Substitol, prolonged‐release capsule, hard, 200, mg, Pack: 30 |
Mundipharma GmbH, Австрия |
Bard Pharmaceutical Ltd., UK; Mundipharma GmbH, Germany; Mundipharma Ges.m.b.H, Austria |
101.61 |
20.32 |
121.93 |
4% |
4.06 |
105.67 |
21.13 |
126.8 |
16% |
16.26 |
121.93 |
24.39 |
146.32 |
Промяна на обстоятелства НСР-15299/23.03.2018 |
КЦ-692/09.03.2009 |
24.03.2009 |
02.05.2018 |
Активен |
637 |
| Morphine |
II-4223/16.02.2009 |
Substitol, prolonged‐release capsule, hard, 200, mg, Pack: 30 |
Mundipharma GmbH, Австрия |
Bard Pharmaceutical Ltd., UK; Mundipharma GmbH, Germany; Mundipharma Ges.m.b.H, Austria |
101.61 |
20.32 |
121.93 |
4% |
4.06 |
105.67 |
21.13 |
126.8 |
16% |
16.26 |
121.93 |
24.39 |
146.32 |
|
КЦ-692/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
637 |
| Morphine |
II-4222/16.02.2009 |
Substitol, prolonged-release capsule, hard, 120, mg, Pack: 30 |
Mundipharma GmbH, Австрия |
Bard Pharmaceutical Ltd., UK; Mundipharma GmbH, Germany; Mundipharma Ges.m.b.H, Austria |
71.23 |
14.25 |
85.48 |
4% |
2.85 |
74.08 |
14.82 |
88.9 |
16% |
11.4 |
85.48 |
17.1 |
102.58 |
|
КЦ-692/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
636 |
| Morphine |
II-4223/16.02.2009 |
Substitol, prolonged‐release capsule, hard, 200, mg, Pack: 30 |
Mundipharma GmbH, Австрия |
Bard Pharmaceutical Ltd., UK; Mundipharma GmbH, Germany; Mundipharma Ges.m.b.H, Austria |
101.61 |
20.32 |
121.93 |
4% |
4.06 |
105.67 |
21.13 |
126.8 |
16% |
16.26 |
121.93 |
24.39 |
146.32 |
|
КЦ-692/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
637 |
| Metoprolol |
20130400 |
Succiprol, Prolonged release tablet, 47.5 mg (съответстващ на 50 mg metoprolol tartrate), -, Pack: 60 |
Teva B.V., Нидерландия |
Merckle GmbH, Германия; Teva Pharma B.V., Нидерландия |
6.92 |
1.38 |
8.3 |
7% |
0.48 |
7.4 |
1.48 |
8.88 |
20% |
1.38 |
8.78 |
1.76 |
10.54 |
Прот. № 136/16.09.2015; Промяна на обстоятелствата НСР-17084/26.10.2018 |
НСР-4584/15.09.2014; НСР-17441/06.12.2018 |
21.12.2018 |
02.01.2019 |
Активен |
3169 |
| Metoprolol |
20130401 |
Succiprol, Prolonged release tablet, 95 mg (съответстващ на 100 mg metoprolol tartrate), -, Pack: 60 |
Teva B.V., Нидерландия |
Merckle GmbH, Германия
Teva Pharma B.V., Нидерландия |
10.35 |
2.07 |
12.42 |
6% |
0.62 |
10.97 |
2.19 |
13.16 |
18% |
1.86 |
12.83 |
2.57 |
15.4 |
Промяна на обстоятелствата НСР-17084/26.10.2018 |
НСР-4585/15.09.2014; НСР-17325/22.11.2018 |
07.12.2018 |
02.01.2019 |
Активен |
3168 |
| Metoprolol |
20130400 |
Succiprol 47.5 mg, Prolonged release tablet, 50 mg (съответстващ на 50 mg metoprolol tartrate), -, Pack: 60 |
Teva B.V., Нидерландия |
Merckle GmbH, Германия; Teva Pharma B.V., Нидерландия |
6.92 |
1.38 |
8.3 |
7% |
0.48 |
7.4 |
1.48 |
8.88 |
20% |
1.38 |
8.78 |
1.76 |
10.54 |
Прот. № 136/16.09.2015; Промяна на обстоятелствата НСР-17084/26.10.2018 |
НСР-4584/15.09.2014; НСР-17441/06.12.2018 |
21.12.2018 |
02.01.2019 |
Неактивен |
3169 |
| Metoprolol |
20130400 |
Succiprol 47.5 mg, Prolonged release tablet, 50 mg (съответстващ на 50 mg metoprolol tartrate), -, Pack: 60 |
Teva B.V., Нидерландия |
Merckle GmbH, Германия
Teva Pharma B.V., Нидерландия |
7.2 |
1.44 |
8.64 |
7% |
0.5 |
7.7 |
1.54 |
9.24 |
20% |
1.44 |
9.14 |
1.83 |
10.97 |
Прот. № 136/16.09.2015; Промяна на обстоятелствата НСР-17084/26.10.2018 |
НСР-4584/15.09.2014 |
30.09.2014 |
02.12.2018 |
Неактивен |
3169 |
| Metoprolol |
20130400 |
Succiprol 47.5 mg, Prolonged release tablet, 50 mg (съответстващ на 50 mg metoprolol tartrate), -, Pack: 60 |
Тева Фармасютикълс България ЕООД, България |
Merckle GmbH, Германия
Teva Pharma B.V., Нидерландия |
7.2 |
1.44 |
8.64 |
7% |
0.5 |
7.7 |
1.54 |
9.24 |
20% |
1.44 |
9.14 |
1.83 |
10.97 |
Прот. № 136/16.09.2015 |
НСР-4584/15.09.2014 |
30.09.2014 |
30.09.2014 |
Неактивен |
3169 |
| Metoprolol |
20130401 |
Succiprol 95 mg, Prolonged release tablet, 100 mg (съответстващ на 100 mg metoprolol tartrate), -, Pack: 60 |
Teva B.V., Нидерландия |
Merckle GmbH, Германия
Teva Pharma B.V., Нидерландия |
10.35 |
2.07 |
12.42 |
6% |
0.62 |
10.97 |
2.19 |
13.16 |
18% |
1.86 |
12.83 |
2.57 |
15.4 |
Промяна на обстоятелствата НСР-17084/26.10.2018 |
НСР-4585/15.09.2014; НСР-17325/22.11.2018 |
07.12.2018 |
02.01.2019 |
Неактивен |
3168 |
| Metoprolol |
20130401 |
Succiprol 95 mg, Prolonged release tablet, 100 mg (съответстващ на 100 mg metoprolol tartrate), -, Pack: 60 |
Teva B.V., Нидерландия |
Merckle GmbH, Германия
Teva Pharma B.V., Нидерландия |
14.39 |
2.88 |
17.27 |
6% |
0.86 |
15.25 |
3.05 |
18.3 |
18% |
2.59 |
17.84 |
3.57 |
21.41 |
Промяна на обстоятелствата НСР-17084/26.10.2018 |
НСР-4585/15.09.2014 |
30.09.2014 |
02.12.2018 |
Неактивен |
3168 |
| Metoprolol |
20130401 |
Succiprol 95 mg, Prolonged release tablet, 100 mg (съответстващ на 100 mg metoprolol tartrate), -, Pack: 60 |
Тева Фармасютикълс България ЕООД, България |
Merckle GmbH, Германия
Teva Pharma B.V., Нидерландия |
14.39 |
2.88 |
17.27 |
6% |
0.86 |
15.25 |
3.05 |
18.3 |
18% |
2.59 |
17.84 |
3.57 |
21.41 |
|
НСР-4585/15.09.2014 |
30.09.2014 |
30.09.2014 |
Неактивен |
3168 |
| Sufentanil |
II-14065/14.08.2006 |
Sufentanil Torrex sol. inj. 50 mcg/ml 5 ml x 5, Solution for injection, 0.25, mg/5ml, Pack: 5 |
Torrex Chiesi Pharma GmbH, Австрия |
Torrex Chiesi Pharma GmbH, Gonsagagasse 1616, Viena 1010 Austria |
35.83 |
7.17 |
43 |
4% |
1.43 |
37.26 |
7.45 |
44.71 |
16% |
5.73 |
42.99 |
8.6 |
51.59 |
корекц. НСP-545/11.07.2013Цената се заличава с решение НСР-1233/23.09.2013 |
HCР-64/07.06.2013. |
26.06.2013 |
26.06.2013 |
Заличен |
1975 |
| Sufentanil |
II-14065/14.08.2006 |
Sufentanil Torrex sol. inj. 50 mcg/ml 5 ml x 5, Solution for injection, 0.25, mg/5ml, Pack: 5 |
Torrex Chiesi Pharma GmbH, Австрия |
Torrex Chiesi Pharma GmbH, Gonsagagasse 1616, Viena 1010 Austria |
35.85 |
7.17 |
43.02 |
4% |
1.43 |
37.28 |
7.46 |
44.74 |
16% |
5.74 |
43.02 |
8.6 |
51.62 |
|
КЦ-450/21.01.2009 |
11.02.2009 |
11.02.2009 |
Неактивен |
1975 |